Thalassemias and their dental implications;Las talasemias y sus implicaciones odontológicas

Medicina Oral

Volumn 7, Issue 1, 2002, Pages 36-45

  Cutando Soriano, Antonio ^a   Gil Montoya, José Antonio ^a   López González Garrido, Juan De Dios ^a  

^a Facultad de Odontologia   (Spain)

Author keywords

Dental care; Thalassemias

Indexed keywords

ANEMIA; ARTICLE; BLOOD TRANSFUSION; DENTAL CARE; DENTIST; FACIAL BONE; GENE THERAPY; HUMAN; MALOCCLUSION; MEDICAL RESEARCH; THALASSEMIA; TOOTH DISEASE; CLASSIFICATION; FACE MALFORMATION; FACIES; LIVER FUNCTION TEST; REVIEW;

CHELATING AGENT;

CHELATING AGENTS; FACIES; HUMANS; LIVER FUNCTION TESTS; MALOCCLUSION; MAXILLOFACIAL ABNORMALITIES; THALASSEMIA;

EID: 1842865824     PISSN: 11372834     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. The thalassemias
2. Talasemias
3. Liver iron and fibrosis during long term treatment with deferiprone in Swiss thalassaemic patients
4. Thalassemia major: Older patients, new therapies
5. Salivary measurement of deferiprone concentrations and correlation with serum levels
6. Changes in the parotid salivary glan of beta thalassemia patients due to hemosiderin deposits
7. Oromaxillofacial changes in thalassemia major
8. Bimaxillary hyperplasia: The facial expresion of homozygous beta-thalassemia
9. Maxillary implant surgery on a patient with thalassemia
10. Anomalies of the masticatory apparatus in beta-thalassemia. The present status after transfusion and iron chelating therapy
11. Homozygous beta thalassemia in an African-American pediatric patient
12. Deferiprone: A review of its clinical potential in iron overload in beta-thalassaemia major and other transfusion dependent diseases
13. Iron chelation with oral deferiprone in patients with thalassemia
14. Liver iron and fibrosis during long term treatment with deferiprone in Swiss thalassaemic patients
15. Results of long term deferiprone (L1) therapy: A report by the Internationnal Study Group on Iraon chelators
16. Agranulocytosis, arthritis and systemic vasculitis in a patient receiving the oral iron chelator L1 (deferiprone)
17. The role of recombinat human erythropoietin in the treatment of thalassemia
18. Elimination of transfusions through induction of fetal hemobiobin synthesis in Cooley's anemia
19. Pharmacologic treatment of thalassemia intermedia with hydroxyurea
20. Oral aspects and management of severe graft-vs-host disease in a young patient with B-thalassemia: Case report
21. Bone marrow transplantation for thalassemia and other inherited disorders of hemoglobin
22. Management of Cooley's anaemia